台股 » 晟德 » 個股財報 » 每月營收

晟德

(4123)
可現股當沖
  • 股價
    37.65
  • 漲跌
    ▲0.10
  • 漲幅
    +0.27%
  • 成交量
    958
  • 產業
    上櫃 生技醫療類股 ▼0.48%
  • 本地時間:13:30(已收盤)

    416人加入追蹤

    立即追蹤

晟德 (4123) 財務報表-每月營收
月營收報表

因應IFRSs國際會計準則,本報表在2013年以前為「個別營收」,2013年以後為「合併營收」。

晟德 (4123) 月營收分析比較圖

晟德 (4123) 月營收報表

年度/月份營業收入(單位:千元)累計營業收入(單位:千元)
單月營收去年同月營收單月月增率單月年增率累計營收去年累計營收累積年增率
2025/10134,696196,6933.5%-31.5%1,251,3731,366,009-8.4%
2025/09130,173105,42039.3%23.5%1,116,6771,169,316-4.5%
2025/0893,459147,602-31.2%-36.7%986,5041,063,896-7.3%
2025/07135,779140,47320.2%-3.3%893,045916,294-2.5%
2025/06112,968120,402-11.8%-6.2%757,266775,821-2.4%
2025/05128,116150,836-7.3%-15.1%644,298655,419-1.7%
2025/04138,163141,17345.3%-2.1%516,182504,5832.3%
2025/0395,056116,847-40.8%-18.6%378,019363,4104%
2025/02160,66893,99431.4%70.9%282,963246,56314.8%
2025/01122,295152,5691.4%-19.8%122,295152,569-19.8%
2024/12120,569145,104-9.1%-16.9%1,619,2531,394,00616.1%
2024/11132,675126,767-32.5%4.7%1,498,6841,248,90220%
2024/10196,693133,65586.6%47.2%1,366,0091,122,13521.7%
2024/09105,420115,265-28.6%-8.5%1,169,316988,48018.3%
2024/08147,602120,8845.1%22.1%1,063,896873,21521.8%
2024/07140,473105,01816.7%33.8%916,294752,33121.8%
2024/06120,402101,341-20.2%18.8%775,821647,31319.9%
2024/05150,836112,7046.8%33.8%655,419545,97220%
2024/04141,17396,90720.8%45.7%504,583433,26816.5%
2024/03116,847103,98624.3%12.4%363,410336,3618%
2024/0293,994122,598-38.4%-23.3%246,563232,3756.1%
2024/01152,569109,7775.1%39%152,569109,77739%
2023/12145,10470,33414.5%106.3%1,394,006767,24581.7%
2023/11126,76782,466-5.2%53.7%1,248,902696,91179.2%
2023/10133,65585,89515.9%55.6%1,122,135614,44582.6%
2023/09115,26569,332-4.6%66.3%988,480528,55087%
2023/08120,88455,02215.1%119.7%873,215459,21890.2%
2023/07105,01847,5683.6%120.8%752,331404,19686.1%
2023/06101,34159,528-10.1%70.2%647,313356,62881.5%
2023/05112,70480,74516.3%39.6%545,972297,10083.8%
2023/0496,90764,348-6.8%50.6%433,268216,355100.3%
2023/03103,98654,991-15.2%89.1%336,361152,007121.3%
2023/02122,59829,35711.7%317.6%232,37597,016139.5%
2023/01109,77767,65956.1%62.3%109,77767,65962.3%
2022/1270,33441,378-14.7%70%767,722500,10753.5%
2022/1182,46644,227-4%86.5%697,388458,72952%
晟德轉投資寶濟藥業 預計12月上旬於香港掛牌上市Anue鉅亨-7天前
櫃買中心「台灣生技產業高峰論壇」7/24登場 晟德、太醫等7家法說Anue鉅亨-2025/07/17
晟德轉投資加科思KRAS抑制劑獲中國藥證 1.9億元里程碑金入袋Anue鉅亨-2025/05/23
晟德 相關文章